Correction: Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4a) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains

PLoS ONE - United States
doi 10.1371/journal.pone.0116131
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Public Library of Science (PLoS)

Related search

The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Development of Cell-Based Assays for in Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

Journal of Clinical and Translational Hepatology
2013English

Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes From Patients Infected With Hepatitis C Virus Genotypes 5 and 6

Journal of Clinical Microbiology
Microbiology
2016English

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Unraveling the Structural Basis of Grazoprevir Potency Against Clinically Relevant Substitutions in Hepatitis C Virus NS3/4A Protease From Genotype 1a

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy